These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19148961)

  • 1. Drug-eluting versus bare-metal stents in acute myocardial infarction.
    Rothman KJ
    N Engl J Med; 2009 Jan; 360(3):301; author reply 301-2. PubMed ID: 19148961
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting versus bare-metal stents in acute myocardial infarction.
    Kim DH
    N Engl J Med; 2009 Jan; 360(3):300-1; author reply 301-2. PubMed ID: 19148960
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
    Roukoz H; Bavry AA; Sarkees ML; Mood GR; Kumbhani DJ; Rabbat MG; Bhatt DL
    Am J Med; 2009 Jun; 122(6):581.e1-10. PubMed ID: 19486720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting versus bare-metal stents in acute myocardial infarction.
    Wong BY
    N Engl J Med; 2009 Jan; 360(3):300; author reply 301-2. PubMed ID: 19144948
    [No Abstract]   [Full Text] [Related]  

  • 5. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
    Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?
    Finn AV; Nakazawa G; Kolodgie F; Virmani R
    Eur Heart J; 2009 Aug; 30(15):1828-30. PubMed ID: 19515688
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance of risks and benefits of drug-eluting versus bare-metal stents.
    Pfisterer M; Brunner-La Rocca HP; Kaiser C
    J Am Coll Cardiol; 2008 Mar; 51(9):972; author reply 972-3. PubMed ID: 18308171
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcomes of serolimus-eluting stents versus bare metal stents in ST-segment elevation myocardial infarction patients: a meta-analysis.
    Pan XH; Zhong WZ; Xiang MX; Xu G; Shan J; Wang JA
    Chin Med J (Engl); 2009 Jan; 122(1):88-92. PubMed ID: 19187623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.
    Leibundgut G; Nietlispach F; Pittl U; Brunner-La Rocca H; Kaiser CA; Pfisterer ME
    Am Heart J; 2009 Aug; 158(2):271-6. PubMed ID: 19619705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents.
    Ko DT; Chiu M; Guo H; Austin PC; Marquis JF; Tu JV
    Am Heart J; 2009 Oct; 158(4):592-598.e1. PubMed ID: 19781419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria.
    Carlsson J; James SK; Lindbäck J; Scherstén F; Nilsson T; Stenestrand U; Lagerqvist B;
    J Am Coll Cardiol; 2009 Apr; 53(16):1389-98. PubMed ID: 19371822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
    Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.